BAVENCIO is the FIRST and ONLY approved immunotherapy maintenance treatment for certain patients with advanced urothelial carcinoma (UC)
BAVENCIO is a prescription medicine used to treat a type of cancer in the bladder or urinary tract called urothelial carcinoma (UC) when it has spread or cannot be removed by surgery (advanced UC).
BAVENCIO is an immunotherapy—a medicine that may treat certain cancers by working with your immune system.
It’s important to share information about yourself and your medical history with your healthcare provider and discuss possible limitations you may have when taking this treatment.
Before you receive BAVENCIO, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
See the chart below to help you understand when BAVENCIO may be prescribed: